Correlation Between Immix Biopharma and Karuna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Karuna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Karuna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Karuna Therapeutics, you can compare the effects of market volatilities on Immix Biopharma and Karuna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Karuna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Karuna Therapeutics.

Diversification Opportunities for Immix Biopharma and Karuna Therapeutics

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Immix and Karuna is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Karuna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karuna Therapeutics and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Karuna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karuna Therapeutics has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Karuna Therapeutics go up and down completely randomly.

Pair Corralation between Immix Biopharma and Karuna Therapeutics

Given the investment horizon of 90 days Immix Biopharma is expected to generate 2.94 times more return on investment than Karuna Therapeutics. However, Immix Biopharma is 2.94 times more volatile than Karuna Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Karuna Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  150.00  in Immix Biopharma on September 1, 2024 and sell it today you would earn a total of  61.00  from holding Immix Biopharma or generate 40.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy31.11%
ValuesDaily Returns

Immix Biopharma  vs.  Karuna Therapeutics

 Performance 
       Timeline  
Immix Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.
Karuna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Karuna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Karuna Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Immix Biopharma and Karuna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immix Biopharma and Karuna Therapeutics

The main advantage of trading using opposite Immix Biopharma and Karuna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Karuna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karuna Therapeutics will offset losses from the drop in Karuna Therapeutics' long position.
The idea behind Immix Biopharma and Karuna Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges